Peer-reviewedCC BYJournal of clinical medicine
Tumor Clusterin Expression at Diagnosis Is Associated with Residual Disease Burden After Neoadjuvant Chemotherapy in Breast Cancer
8 affiliations
- 1Telecommunication Research Institute (TELMA), E.T.S. Ingeniería de Telecomunicación and Mobilenet, , 29071 Malaga, Spain
- 2Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina—IBIMA Plataforma BIONAND, 29590 Malaga, Spain
- 3Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) and Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), 29603 Marbella, Spain
- 4Department of Oncology, Hospital Universitario Costa del Sol, Autovía A-7, Km 187, 29603 Marbella, Spain
- 5Department of Pathology, , 41013 Sevilla, Spain
- 6Department of Oncology, San Cecilio University Hospital, 18016 Granada, Spain
- 7Department of Oncology, Virgen Macarena University Hospital, 41009 Sevilla, Spain
- 8Clinical Laboratories Area, Hospital Universitario Costa del Sol, Autovía A-7, Km 187, 29603 Marbella, Spain
Related
- Prognostic Significance of p53 Immunohistochemical Expression and Molecular Characterization of TP53 Variants in Triple-Negative Breast Cancer After Neoadjuvant Chemotherapy
- Neoadjuvant Chemotherapy and Perioperative Complications Associated with Pulmonary Toxicity.
- Single-cell and spatial transcriptomics reveal a DLL4-associated tip-like endothelial niche linked to neoadjuvant chemotherapy non-response in muscle-invasive bladder cancer.
- Neoadjuvant chemotherapy in locally advanced colon cancer: lessons from the NeoCol trial and the limits of anatomical risk stratification.
- Correlation of Axillary Nodal with Breast Response Following Neoadjuvant Chemotherapy in Early Breast Cancer
BibTeX
@article{garciaaranda2026tumor,
title = {{Tumor Clusterin Expression at Diagnosis Is Associated with Residual Disease Burden After Neoadjuvant Chemotherapy in Breast Cancer}},
author = {Marilina García-Aranda and Desirée Martín-García and Irene Zarcos-Pedrinaci and Diego Pérez and Ioana-Cristina Tugulea-Teodorovici and Sergio A. Rodríguez-Lobalzo and Francisco Rivas-Ruiz and Francisco-Javier Martínez-Barrios and Gema Civantos and Marta Legeren and Nicolás Gallego-Pena and Esteban Nogales and María Luisa Hortas and Raquel Barco and Cristina Quero and Maximino Redondo},
journal = {Journal of clinical medicine},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13665789},
note = {CC BY},
}
RIS
TY - JOUR
TI - Tumor Clusterin Expression at Diagnosis Is Associated with Residual Disease Burden After Neoadjuvant Chemotherapy in Breast Cancer
AU - Marilina García-Aranda
AU - Desirée Martín-García
AU - Irene Zarcos-Pedrinaci
AU - Diego Pérez
AU - Ioana-Cristina Tugulea-Teodorovici
AU - Sergio A. Rodríguez-Lobalzo
AU - Francisco Rivas-Ruiz
AU - Francisco-Javier Martínez-Barrios
AU - Gema Civantos
AU - Marta Legeren
AU - Nicolás Gallego-Pena
AU - Esteban Nogales
AU - María Luisa Hortas
AU - Raquel Barco
AU - Cristina Quero
AU - Maximino Redondo
PY - 2026
DA - 2026/09/29
JO - Journal of clinical medicine
UR - https://europepmc.org/article/PMC/PMC13665789
SN - 2077-0383
ER -